Doxorubicin Hydrochloride Liposome in the United States

3 medicine records from 2 holders carry this name in the official sources. Collected on November 21, 2026.

Medicines

Holders and status of these records
Name Holder Code
Doxorubicin Hydrochloride Liposome INJECTION, SUSPENSION, LIPOSOMAL Baxter Healthcare Company Product NDC 0338-0080Package NDC 0338-0080-01
Doxorubicin Hydrochloride Liposome INJECTION, SUSPENSION, LIPOSOMAL Baxter Healthcare Company Product NDC 0338-0086Package NDC 0338-0086-01
Doxorubicin Hydrochloride Liposome INJECTION, SUSPENSION, LIPOSOMAL Sagent Pharmaceuticals Product NDC 25021-263Package NDC 25021-263-10

Need this list in your own system?

Every record on this page is available through the API, with its source, licence and retrieval date.